Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas.

The benefits of radio-chemotherapy in HIV-negative primary central nervous system (CNS) lymphomas were analyzed in 40 patients, who received radiotherapy to the brain or craniospinal axis with the total dose of 4460-5940 cGy to the primary tumor. Radiotherapy was followed by systemic chemotherapy, m...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, H. G., Kim, I. H., Ha, S. W., Park, C. I., Bang, Y. J., Huh, D. S.
Formato: Texto
Lenguaje:English
Publicado: Korean Academy of Medical Sciences 1999
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054450/
https://www.ncbi.nlm.nih.gov/pubmed/10576154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054450/
https://www.ncbi.nlm.nih.gov/pubmed/10576154

Ejemplares similares